DT389-YP7, a Recombinant Immunotoxin against Glypican-3 That Inhibits Hepatocellular Cancer Cells: An In Vitro Study
Hepatocellular carcinoma (HCC) is one of the high-metastatic types of cancer, and metastasis occurs in one-third of patients with HCC. To maintain the effectiveness of drug compounds on cancer cells and minimize their side effects on normal cells, it is important to use new approaches for overcoming...
Enregistré dans:
Auteurs principaux: | Hamid Hashemi Yeganeh, Mohammad Heiat, Marek Kieliszek, Seyed Moayed Alavian, Ehsan Rezaie |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2e5e1fe43e934ac890c9e94c1a657670 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
IMMUNOHISTOCHEMICAL EXPRESSION OF GLYPICAN-3 IN HEPATOCELLULAR CARCINOMA
par: Dr Syed Salman Ali, et autres
Publié: (2018) -
Antibody-Based Immunotoxins for Colorectal Cancer Therapy
par: Laura Sanz, et autres
Publié: (2021) -
Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin
par: AVILA,ANA D, et autres
Publié: (2007) -
Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential
par: Yu Y, et autres
Publié: (2017) -
PRODUCTION OF RECOMBINANT PROTEIN CRM197 IN ESCHERICHIA COLI
par: I. V. Dukhovlinov, et autres
Publié: (2015)